About 1 result found for searched term "1616428-23-9" (0.121 seconds)
Cat.No. | Name | Target |
---|---|---|
M10850 | Luxeptinib | FLT3 |
CG-806 | ||
Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent pan-FLT3/pan-BTK inhibitor. Luxeptinib induces cell cycle blocking, apoptosis, or autophagy in acute myeloid leukemia. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.